Causes and solutions to infertility in men

Infertility affects couples worldwide and is a shared problem: roughly half of infertility cases involve a male factor either alone or in combination with female factors. In many regions, estimates indicate a substantial number of couples are affected and that male causes account for approximately 40% of diagnosed infertility. Historically, clinical attention focused more on female evaluation, but in recent decades the diagnostic workup and treatment options for male infertility have expanded considerably — including sperm selection techniques such as intracytoplasmic morphologically selected sperm injection (IMSI) and advanced sperm retrieval methods for men with low or absent sperm in the ejaculate [1–4].

This article provides a clinical overview of the main causes of male infertility, the diagnostic approach, evidence‑based treatment options, and practical prevention and counseling measures. The content is intended for medical/health education and is based on guidelines and resources from major clinical organizations and institutions.

Overview and epidemiology

Infertility is classically defined as the inability to achieve a clinical pregnancy after 12 months of regular, unprotected intercourse for couples in which the female partner is under age 35; for women 35 and older, evaluation is often initiated after 6 months [1,2].
Male factor infertility contributes to nearly half of infertility cases; it may be the sole cause or a contributing factor alongside female causes [2,3].
Multiple studies indicate population-level declines in some semen parameters over recent decades; environmental, lifestyle, and occupational contributors are being investigated, but causal relationships are complex and multifactorial [3,4].

(References and official links are listed at the end of the article.)

How male fertility is evaluated

A systematic evaluation of the male partner is essential and should be coordinated with the female assessment. The evaluation generally includes:

Thorough medical, reproductive, sexual, and occupational history. Important details include prior fertility or paternity, duration and frequency of attempts to conceive, use of contraception, prior urogenital surgeries (e.g., hernia repair), history of infections (mumps, sexually transmitted infections), exposures to gonadotoxins (chemotherapy, radiation), medications (e.g., exogenous androgens, certain psychotropic or antihypertensive drugs), smoking, alcohol and substance use, and occupational exposures to heat or chemicals.
Physical examination focusing on secondary sexual characteristics, testicular size and consistency, presence of varicoceles, and abnormalities of the penis or scrotum.
Semen analysis: the cornerstone test. A minimum of two separate semen analyses is recommended, performed after 2–7 days of sexual abstinence. Parameters assessed include volume, sperm concentration (count), motility, and morphology. Additional specialized tests (e.g., sperm DNA fragmentation) may be indicated in select cases [2–4].
Endocrine testing: measurement of serum follicle-stimulating hormone (FSH), luteinizing hormone (LH), total testosterone, and sometimes prolactin or estradiol, particularly when sperm concentration is low or absent.
Genetic testing: karyotype and Y‑chromosome microdeletion testing are considered when sperm concentration is severely reduced or absent (e.g., nonobstructive azoospermia) [2].
Imaging and targeted studies: scrotal ultrasound to evaluate the testes and varicoceles; transrectal ultrasound if obstruction of the ejaculatory ducts is suspected; post‑ejaculatory urine analysis if retrograde ejaculation is a concern [2,3].

Major causes of male infertility

Etiologies can be grouped into pre‑testicular (endocrine), testicular (spermatogenesis disorders), and post‑testicular (obstructive or ejaculatory) causes.

Pre‑testicular (endocrine) causes

These involve disruptions to the hypothalamic‑pituitary‑testicular axis that impair stimulation of spermatogenesis.

Hypogonadotropic hypogonadism: low gonadotropins (FSH, LH) and low testosterone due to hypothalamic or pituitary disorders. Causes include congenital conditions, tumors, trauma, systemic illness, or medications.
Hyperprolactinemia: elevated prolactin can suppress GnRH and gonadotropin secretion, impairing sperm production.
Exogenous testosterone and anabolic steroid use: suppresses endogenous gonadotropin secretion, causing testicular atrophy and reduced sperm production — often reversible but may take months to years to recover [2,3].

Testicular causes (primary testicular failure and impaired spermatogenesis)

Varicocele: dilated testicular veins (varicocele) are a common, potentially reversible cause of impaired sperm parameters, especially on the left side. Varicoceles can increase scrotal temperature and oxidative stress, affecting sperm production and function [3,4].
Genetic abnormalities: chromosomal anomalies (e.g., Klinefelter syndrome, 47,XXY) and Y‑chromosome microdeletions can impair spermatogenesis and are important to diagnose as they affect prognosis and reproductive counseling [2].
Congenital anomalies: undescended testes (cryptorchidism) can reduce fertility risk, especially if not corrected early in life.
Testicular injury, torsion, or surgical damage.
Infections and inflammation: mumps orchitis in puberty or adulthood can cause testicular damage. Chronic infections (e.g., epididymitis) may also impair function.
Systemic illnesses and metabolic disease: diabetes, obesity, and chronic systemic diseases may negatively affect spermatogenesis and sexual function.
Idiopathic testicular failure: in many men no specific cause is identified despite thorough evaluation.

Post‑testicular causes (obstruction and ejaculatory dysfunction)

Obstructive azoospermia: obstruction in the reproductive tract (e.g., vas deferens, epididymis, ejaculatory ducts) prevents sperm from appearing in the ejaculate despite normal spermatogenesis. Causes include prior vasectomy, congenital bilateral absence of the vas deferens (CBAVD), infections, or iatrogenic injury.
Ejaculatory dysfunction: disorders of ejaculation (e.g., retrograde ejaculation where semen flows into the bladder) and neurological conditions can prevent effective sperm delivery.
Sperm transport issues due to structural anomalies or scarring.

Sperm quality and DNA integrity

Abnormalities in sperm concentration, motility, and morphology are commonly detected in semen analyses. Additionally, sperm DNA fragmentation — damage to the genetic material in sperm — is increasingly recognized as a factor that can impair embryo development and increase miscarriage risk; testing may be considered in recurrent pregnancy loss or unexplained infertility [3,4].

Lifestyle, environmental, and occupational contributors

Multiple modifiable factors can impair semen quality:

Smoking and excessive alcohol use have negative effects on sperm concentration, motility, and morphology.
Obesity and metabolic syndrome are associated with hormonal alterations and reduced semen quality.
Heat exposure to the testes (frequent hot baths, saunas, occupational heat exposure) can reduce sperm production.
Environmental and occupational exposures to pesticides, heavy metals, phthalates, and other endocrine-disrupting chemicals may contribute to reduced sperm quality.
Advanced paternal age is associated with gradual declines in semen quality and higher rates of de novo genetic changes, although the effects are less dramatic than maternal age effects [3,4].

Diagnostic approach in practice

Begin with a comprehensive history and focused physical examination.
Obtain at least two semen analyses spaced several weeks apart.
If semen analysis is abnormal, evaluate endocrine function (FSH, LH, testosterone). Elevated FSH with small testes suggests primary testicular failure; low or normal FSH with low testosterone suggests hypogonadotropic hypogonadism.
If azoospermia is present, distinguish obstructive from nonobstructive causes with endocrine testing and scrotal imaging; consider genetic testing (karyotype, Y microdeletions) and cystic fibrosis (CFTR) testing when CBAVD is suspected.
Consider additional testing (sperm DNA fragmentation assays, post‑ejaculatory urine) when indicated by clinical history [2–4].

Clinical guidelines emphasize coordinated evaluation of both partners and timely referral to reproductive endocrinology or urology specialists when needed.

Treatment options

Treatment is tailored to the identified cause and fertility goals of the couple. Options range from lifestyle modification and medical therapy to surgical correction and assisted reproductive technology (ART).

General measures and lifestyle modification

For many men with suboptimal semen parameters, optimizing general health improves reproductive potential:

Smoking cessation and limiting alcohol intake.
Achieving and maintaining a healthy weight and managing comorbidities such as diabetes and hypertension.
Avoiding excessive heat exposure and tight-fitting underwear; recommending loose-fitting undergarments and avoidance of prolonged hot baths or saunas.
Avoiding known gonadotoxins when possible (e.g., certain chemotherapy agents, illicit anabolic steroids); consult with a clinician about medication adjustments where feasible.
Addressing occupational exposures with workplace modifications as needed.
Nutritional optimization and regular moderate exercise.
Consideration of stopping nonessential supplements or medications known to impair fertility, under clinician guidance [2–4].

Medical therapy

Treatment of endocrine disorders: men with hypogonadotropic hypogonadism may respond to gonadotropin therapy (human chorionic gonadotropin [hCG] with or without follicle-stimulating hormone [FSH]) to stimulate spermatogenesis. Selective estrogen receptor modulators (e.g., clomiphene citrate) and aromatase inhibitors are used in some cases to raise endogenous gonadotropin and testosterone levels and may improve semen parameters in men with specific hormonal profiles [2–4].
Antibiotics: appropriate antibiotic therapy for documented bacterial infections (e.g., prostatitis, epididymitis) may be indicated, although the impact on fertility depends on the extent of damage and timing of treatment.
Antioxidant therapy: oxidative stress contributes to sperm dysfunction. Some trials suggest that antioxidant supplementation may improve semen parameters and outcomes in selected men, but evidence is variable; clinicians should counsel patients on the uncertainties and avoid unregulated high-dose combinations without professional supervision [3,4].

Surgical and procedural treatments

Varicocele repair: microsurgical varicocelectomy or percutaneous embolization can improve semen parameters and, in some men, increase spontaneous pregnancy rates. The decision to repair a varicocele depends on semen findings, clinical exam, and the couple’s fertility goals [3].
Correction of obstructive lesions: reconstructive microsurgery (e.g., vasovasostomy for vasectomy reversal, epididymovasostomy for epididymal obstruction) can restore patency and permit natural conception in selected patients. Success depends on the duration of obstruction, surgical expertise, and partner factors.
Transurethral resection or endoscopic procedures: used when ejaculatory duct obstruction is identified.
Sperm retrieval procedures: for men with obstructive azoospermia or nonobstructive azoospermia who wish to pursue ART, sperm can be retrieved directly from the epididymis or testis using techniques such as percutaneous epididymal sperm aspiration (PESA), testicular sperm aspiration (TESA), microdissection testicular sperm extraction (micro-TESE), or open testicular biopsy. Retrieved sperm can be used with intracytoplasmic sperm injection (ICSI) or other ART methods [2–4].

Assisted reproductive technologies (ART)

Intrauterine insemination (IUI): may be appropriate for mild male factor infertility or unexplained infertility; sperm are prepared (washed) and placed in the uterus around the time of ovulation [2].
In vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI): ICSI — injection of a single sperm into an oocyte — revolutionized treatment for male factor infertility and is the primary technique for men with severely impaired semen parameters or surgically retrieved sperm. Variations such as IMSI involve selection of sperm under higher magnification to choose sperm with better morphological characteristics; clinical benefit is debated and may be considered in selected cases or centers with expertise [3,4].
Donor sperm: for men with irreversible azoospermia or genetic conditions incompatible with biological parenthood, donor insemination is an effective option.
Cryopreservation: sperm banking is recommended prior to gonadotoxic therapy (chemotherapy, radiotherapy) or before reversible use of exogenous androgens or anabolic steroids.

Management of ejaculatory dysfunction

Medical therapy (e.g., sympathomimetics for retrograde ejaculation) and behavioral techniques may be effective.
Assisted ejaculation techniques include vibratory stimulation and electroejaculation in selected cases.
When ejaculation cannot be obtained, sperm retrieval from the epididymis or testis with subsequent ART is an effective alternative [2,3].

Outcomes and prognosis

Prognosis depends on the underlying diagnosis, duration of infertility, partner’s reproductive status, and chosen therapeutic approach:

Many couples with mild male factor infertility or correctable causes achieve spontaneous pregnancy following targeted intervention and lifestyle optimization.
Surgical correction (varicocele repair or reconstructive procedures) can meaningfully improve semen parameters and fertility in selected patients, but results are variable and individualized counseling is necessary.
ART, particularly ICSI combined with IVF, has enabled successful conception for many men with severe male factor infertility or after surgical sperm retrieval. Pregnancy and live birth rates depend on maternal factors (age, ovarian reserve), embryo quality, and the specifics of the male condition.
Genetic causes such as Klinefelter syndrome and Y‑chromosome microdeletions carry implications for sperm retrieval success and offspring genetic counseling; preconception genetic counseling and targeted testing are recommended in these scenarios [2,4].

Psychological and relational aspects

Infertility can have profound psychological effects on men and couples. Men frequently report feelings of frustration, loss, decreased self‑esteem, and relationship stress. Historically men may have attributed infertility to their partner, but modern practice emphasizes shared responsibility, joint evaluation, and couple-based counseling. Referral to mental health professionals, support groups, and fertility counseling can improve coping and decision-making throughout diagnosis and treatment [3].

When to seek evaluation

Couples should consider joint evaluation if they have been trying to conceive for 12 months without success (or 6 months if the female partner is 35 or older).
An earlier male evaluation may be appropriate if there is a known risk factor: prior cancer treatment, history of orchitis, prior urologic surgery, known genetic condition, erectile or ejaculatory dysfunction, or suspected obstructive lesions.
Men planning gonadotoxic therapy (chemotherapy, pelvic radiotherapy) should pursue sperm banking before treatment begins [1–3].

Prevention and preconception guidance

While not all causes of male infertility are preventable, several measures can reduce risk and improve fertility potential:

Avoid or limit tobacco, excessive alcohol, and illicit drugs.
Avoid anabolic steroids and exogenous androgens unless medically indicated with fertility considerations discussed.
Maintain a healthy weight and manage chronic medical conditions.
Reduce scrotal heat exposure (avoid prolonged hot tub or sauna use; wear loose clothing).
Use protective equipment and minimize exposure to occupational toxins when possible.
Timely treatment of genitourinary infections and prompt evaluation of testicular pain or swelling.
If genetic risk is present (family history of chromosomal abnormalities, known CFTR mutations), seek genetic counseling before attempting conception [2,3].

Emerging considerations and research directions

Research continues into environmental exposures, endocrine-disrupting chemicals, and their impact on male reproductive health.
Biomarkers such as sperm DNA fragmentation are under active investigation to refine prognostic assessments and guide therapy.
Advances in microsurgical techniques, sperm selection technologies (e.g., IMSI), and ART continue to evolve, with ongoing evaluation of clinical effectiveness and safety [3,4].

Practical takeaways

Male infertility is common and should be evaluated concurrently with female assessment.
Semen analysis is the primary diagnostic test; follow-up endocrine, genetic, and imaging studies are tailored to findings.
Many causes are treatable with lifestyle change, medical therapy, surgical correction, or assisted reproductive technologies, including sperm retrieval and ICSI.
Psychological support and couple-centered counseling are important parts of care.
Early referral to specialists (reproductive urologist or reproductive endocrinologist) is appropriate when initial evaluation suggests significant male factor infertility or when prompt treatment is needed.

References and further reading

American College of Obstetricians and Gynecologists (ACOG). Infertility — Clinical Information. (ACOG patient education and committee opinions on infertility evaluation and management). https://www.acog.org (search “infertility”)

National Institutes of Health — National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Male Reproductive Health and Infertility. https://www.niddk.nih.gov/health-information/urologic-diseases/male-reproductive-health

Mayo Clinic. Male infertility — Symptoms and causes. https://www.mayoclinic.org/diseases-conditions/male-infertility/symptoms-causes/syc-20374773

Cleveland Clinic. Male Infertility: Causes, Symptoms, Diagnosis & Treatment. https://my.clevelandclinic.org/health/diseases/17238-infertility-male

(Consult the linked resources for patient-facing summaries and professional references. For individualized evaluation and treatment, patients should seek consultation with qualified medical providers: reproductive endocrinologists, andrologists, or urologists with expertise in male reproductive health.)